1
|
Rakotoarison A, Scherz M, Glaw F, Köhler J, Andreone F, Franzen M, Glos J, Hawlitschek O, Jono T, Mori A, Ndriantsoa S, Raminosoa N, Riemann J, Rödel MO, Rosa G, Vieites D, Crottini A, Vences M. Describing the smaller majority: integrative taxonomy reveals twenty-six new species of tiny microhylid frogs (genus Stumpffia) from Madagascar. VZ 2017. [DOI: 10.3897/vz.67.e31595] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/16/2023]
|
2
|
Riemann J. Darmkrebsmonat März 2013 - was muss sich ändern? Dtsch Med Wochenschr 2013; 138:411. [DOI: 10.1055/s-0032-1332893] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
3
|
Herzog J, Eickhoff A, Riemann J. Neue Testverfahren in der Präventionsstrategie des kolorektalen Karzinoms. Dtsch Med Wochenschr 2012. [DOI: 10.1055/s-0032-1330144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- J. Herzog
- Medizinische Klinik II, Klinikum Hanau
| | | | | |
Collapse
|
4
|
Hoffmeister A, Mayerle J, Beglinger C, Büchler M, Bufler P, Dathe K, Fölsch U, Friess H, Izbicki J, Kahl S, Klar E, Keller J, Knoefel W, Layer P, Loehr M, Meier R, Riemann J, Rünzi M, Schmid R, Schreyer A, Tribl B, Werner J, Witt H, Mössner J, Lerch M, Lerch MM. S3-Leitlinie Chronische Pankreatitis: Definition, Ätiologie, Diagnostik, konservative, interventionell endoskopische und operative Therapie der chronischen Pankreatitis. Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS). Z Gastroenterol 2012; 50:1176-224. [PMID: 23150111 DOI: 10.1055/s-0032-1325479] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- A. Hoffmeister
- Klinik und Poliklinik für Gastroenterologie und Rheumatologie, Universitätsklinikum Leipzig
| | - J. Mayerle
- Klinik für Innere Medizin A, Universitätsmedizin der Ernst-Moritz-Arndt Universität, Greifswald
| | - C. Beglinger
- Klinik für Gastroenterologie und Hepatologie Universitätsspital Basel, Schweiz
| | - M. Büchler
- Klinik für Allgemeine, Viszerale und Transplantationschirurgie, Universitätsklinikum Heidelberg, Ruprecht-Karls-Universität, Heidelberg
| | - P. Bufler
- Dr. von Haunersches Kinderspital, Ludwig Maximilian Universität München
| | - K. Dathe
- Deutsche Gesellschaft für Verdauungs- und Stoffwechselerkrankungen (DGVS), Berlin
| | - U. Fölsch
- Klinik für Allgemeine Innere Medizin, Christian-Albrechts-Universität zu Kiel
| | - H. Friess
- Chirurgische Klinik und Poliklinik am Klinikum Rechts der Isar, Technische Universität München
| | - J. Izbicki
- Klinik und Poliklinik für Allgemein-, Visceral- und Thoraxchirurgie am Universitätsklinikum Hamburg-Eppendorf
| | - S. Kahl
- Klinik für Innere Medizin Schwerpunkt Gastroenterologie, Hämatologie und Onkologie, Nephrologie DRK Kliniken Berlin-Köpenick
| | - E. Klar
- Allgemeine Chirurgie, Thorax-, Gefäß- und Transplantationschirurgie, Universität Rostock
| | - J. Keller
- Medizinische Klinik, Israelitisches Krankenhaus Hamburg
| | - W. Knoefel
- Klinik für Allgemein-, Viszeral- und Kinderchirurgie, Universitätsklinikum Düsseldorf der Heinrich-Heine-Universität
| | - P. Layer
- Medizinische Klinik, Israelitisches Krankenhaus Hamburg
| | - M. Loehr
- Surgical Gastroenterology, Gastrocentrum, Karolinska University Hospital Huddinge
| | - R. Meier
- Abteilung für Gastroenterologie, Kantonsspital Liestal, Medizinische Universitätsklinik
| | - J. Riemann
- Medizinische Klinik C am Klinikum der Stadt Ludwigshafen/Rhein gGmbH
| | - M. Rünzi
- Klinik für Gastroenterologie u. Stoffwechselerkrankungen, Kliniken Essen Süd
| | - R. Schmid
- Medizinische Klinik 2 am Klinikum Rechts der Isar, Technische Universität München
| | - A. Schreyer
- Institut für Röntgendiagnostik am Universitätsklinikum Regensburg
| | - B. Tribl
- Innere Medizin IV, Abt. f. Gastroenterologie und Hepatologie, Universitätsklinik Wien
| | - J. Werner
- Klinik für Allgemeine, Viszerale und Transplantationschirurgie, Universitätsklinikum Heidelberg, Ruprecht-Karls-Universität, Heidelberg
| | - H. Witt
- Klinik und Poliklinik für Kinder- und Jugendmedizin, Kinderklinik München Schwabing, Technische Universität München
| | - J. Mössner
- Klinik und Poliklinik für Gastroenterologie und Rheumatologie, Universitätsklinikum Leipzig
| | - M. Lerch
- Klinik für Innere Medizin A, Universitätsmedizin der Ernst-Moritz-Arndt Universität, Greifswald
| | | |
Collapse
|
5
|
Riemann J, Layer P. Viszeralmedizin: die Zusammenarbeit hat sich bewährt! Dtsch Med Wochenschr 2012; 137:1791. [DOI: 10.1055/s-0032-1305182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- J. Riemann
- ehem. Direktor der Medizinischen Klinik C, Klinikum der Stadt Ludwigshafen gGmbH
| | - P. Layer
- Medizinische Klinik Israelitisches Krankenhaus Hamburg
| |
Collapse
|
6
|
Riemann J. Darmkrebsprävention: Wie effektiv ist die Screening-Sigmoidoskopie? - Die Sigmoidoskopie ist auch bei uns reif für das Darmkrebsscreening. Dtsch Med Wochenschr 2012; 137:1680. [DOI: 10.1055/s-0032-1301868] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
7
|
Riemann J. Ist die Patientenzufriedenheit ein zweischneidiger Parameter? - Patientenzufriedenheit vielschichtig - kritische Bewertung hilfreich. Dtsch Med Wochenschr 2012; 137:932. [DOI: 10.1055/s-0032-1301869] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
8
|
Riemann J, Webendörfer S. Darmkrebsmonat März 2012: Männer im Fokus. Dtsch Med Wochenschr 2012; 137:361. [DOI: 10.1055/s-0031-1298921] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- J. Riemann
- Vorstandsvorsitzender der Stiftung LebensBlicke
| | - S. Webendörfer
- ehrenamtliches Mitglied des Stiftungsrates der Stiftung LebensBlicke; Vice President Occupational Medicine & Health Protection der BASF SE, Ludwigshafen
| |
Collapse
|
9
|
Malfertheiner P, Riemann J. Viszeralmedizin 2011 – Interdisziplinär auf dem Weg zum kontinuierlichen Fortschritt. Dtsch Med Wochenschr 2011; 136:1769. [DOI: 10.1055/s-0031-1286098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
10
|
Eickhoff A, Enderle M, Hartmann D, Eickhoff J, Riemann J, Jakobs R. Effectiveness and Safety of PRECISE APC for the Treatment of Bleeding Gastrointestinal Angiodysplasia - a Retrospective Evaluation. Z Gastroenterol 2011; 49:195-200. [DOI: 10.1055/s-0029-1245785] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
11
|
Eickhoff A, Riemann J. Gastroenterologie 2010. Dtsch Med Wochenschr 2010; 135:1286-9. [DOI: 10.1055/s-0030-1255155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
12
|
Rothsching M, Riemann J, Salopek S, Jakobs R. Portsysteme und klinischer Umgang mit Ports. Dtsch Med Wochenschr 2010; 135:1134-6. [DOI: 10.1055/s-0030-1255137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
13
|
Riemann J. Check-up-Angebot für Manager: kommt die Früherkennung jetzt in Misskredit? Dtsch Med Wochenschr 2010; 135:812. [DOI: 10.1055/s-0030-1251938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
14
|
Koop H, Riemann J. Viszeralmedizin 2009: Gelebte Interdisziplinarität als Voraussetzung für optimale Behandlungsqualität. Dtsch Med Wochenschr 2009; 134:1803. [DOI: 10.1055/s-0029-1237513] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
15
|
Kohler B, Riemann J. Fall 1664. Dtsch Med Wochenschr 2009. [DOI: 10.1055/s-0029-1235680] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
16
|
Jakobs R, Riemann J. Kommentar. Dtsch Med Wochenschr 2009. [DOI: 10.1055/s-0029-1233693] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
17
|
Weickert U, Zimmerling S, Eickhoff A, Riemann J, Reiss G. A Comparative Scanning Electron Microscopic Study of Biliary and Pancreatic Stents. Z Gastroenterol 2009; 47:347-50. [DOI: 10.1055/s-2008-1027926] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
18
|
Schmiegel W, Reinacher-Schick A, Arnold D, Graeven U, Heinemann V, Porschen R, Riemann J, Rödel C, Sauer R, Wieser M, Schmitt W, Schmoll HJ, Seufferlein T, Kopp I, Pox C. [Update S3-guideline "colorectal cancer" 2008]. Z Gastroenterol 2008; 46:799-840. [PMID: 18759205 DOI: 10.1055/s-2008-1027726] [Citation(s) in RCA: 158] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Affiliation(s)
- W Schmiegel
- Verantwortliche Institution (Leitliniensekretariat): Medizinische Klinik, Knappschaftskrankenhaus, Ruhr-Universität Bochum und die AWMF im Auftrag der DGVS und der DKG (Koordinatoren und Mitglieder der Konferenz siehe Anlage 1 - 3).
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Zeitz M, Riemann J. Viszeralmedizin 2008 – Wissenschaftliche
Fortschritte, Herausforderungen für die Klinik. Dtsch Med Wochenschr 2008; 133:1887. [DOI: 10.1055/s-0028-1085570] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
20
|
Helmstädter L, Helmstädter V, Riemann J. Schmerz im rechten Oberbauch. Dtsch Med Wochenschr 2008; 133:1567-71. [DOI: 10.1055/s-2008-1081111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
21
|
Arnold D, Höhler T, Dittrich C, Lordick F, Seufferlein T, Riemann J, Wöll E, Herrmann T, Zubel A, Schmoll HJ. Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group. Ann Oncol 2008; 19:1442-1449. [PMID: 18441330 DOI: 10.1093/annonc/mdn150] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND This two-part phase Ib/II study investigated the feasibility of administering cetuximab in combination with oxaliplatin and infusional 5-fluorouracil (5-FU)/folinic acid (FA) in a weekly schedule (AIO FUFOX protocol) as first-line treatment in patients with epidermal growth factor receptor-detectable advanced colorectal cancer. PATIENTS AND METHODS Cetuximab was administered weekly: 400 mg/m(2) initial dose, then 250 mg/m(2) and FUFOX: oxaliplatin 50 mg/m(2), FA 500 mg/m(2) and 5-FU as a 24-h infusion at either 1500 or 2000 mg/m(2) administered for 4 weeks followed by a 1-week rest (one cycle). RESULTS Dose-limiting toxicity (grade 3 diarrhea) occurred in 3 of 14 assessable patients receiving 5-FU at standard 2000 mg/m(2). This dose was administered to a further 25 patients. Cetuximab combined with FUFOX was generally well tolerated with the most common grade 3/4 adverse events being diarrhea (27%) and paresthesia (16%). The confirmed response rate for patients receiving 5-FU at standard 2000 mg/m(2) (N = 41) was 56%, with a median duration of 9.3 months. Median progression-free and overall survival times including all 49 patients were 8.1 (95% confidence interval 6.0-9.7) and 28.2 months, respectively. Cetuximab pharmacokinetics seemed not to be different for combination with FUFOX compared with cetuximab/irinotecan combinations. CONCLUSION This protocol is well tolerated and shows promising efficacy supporting further investigation.
Collapse
Affiliation(s)
- D Arnold
- Department of Oncology and Hematology, Martin-Luther-University Halle-Wittenberg, Halle
| | - T Höhler
- Johannes-Gutenberg University Hospital, Mainz, Germany
| | - C Dittrich
- ACR-ITR VIEnna and LBI-ACR VIEnna, Kaiser Franz Josef-Spital, Vienna, Austria
| | - F Lordick
- Klinikum rechts der Isar, Technische Universitaet, Muenchen
| | | | - J Riemann
- Klinikum der Stadt Ludwigshafen, Ludwigshafen, Germany
| | - E Wöll
- University Hospital Innsbruck, Innsbruck, Austria
| | - T Herrmann
- Department of Internal Medicine IV and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg
| | - A Zubel
- Clinical Research and Development, Merck KGaA, Darmstadt, Germany
| | - H-J Schmoll
- Department of Oncology and Hematology, Martin-Luther-University Halle-Wittenberg, Halle.
| |
Collapse
|
22
|
Seufferlein T, Dittrich C, Riemann J, Woell E, Herrmann T, Lordick F, Arnold D, Olchowka K, Hoehler T, Schmoll HJ. A phase I/II study of cetuximab in combination with 5-fluorouracil (5-FU)/folinic acid (FA) plus weekly oxaliplatin (L-OHP) (FUFOX) in the first-line treatment of patients with metastatic colorectal cancer (mCRC) expressing epidermal growth factor receptor (EGFR). Preliminary results. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.3644] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- T. Seufferlein
- Univ Hosp, Ulm, Germany; LBI-ACR VIEnna u. ACR-ITR VIEnna, Oncol. KFJ, Vienna, Austria; Klin der Stadt, Ludwigshafen, Germany; Univ Hosp, Innsbruck, Austria; Univ Hosp, Heidelberg, Germany; Klin rechts der Isar der TU Muenchen, Munich, Germany; Martin-Luther-University Hosp, Halle, Germany; Merck KGaA, Darmstadt, Germany; Univ Hosp, Mainz, Germany
| | - C. Dittrich
- Univ Hosp, Ulm, Germany; LBI-ACR VIEnna u. ACR-ITR VIEnna, Oncol. KFJ, Vienna, Austria; Klin der Stadt, Ludwigshafen, Germany; Univ Hosp, Innsbruck, Austria; Univ Hosp, Heidelberg, Germany; Klin rechts der Isar der TU Muenchen, Munich, Germany; Martin-Luther-University Hosp, Halle, Germany; Merck KGaA, Darmstadt, Germany; Univ Hosp, Mainz, Germany
| | - J. Riemann
- Univ Hosp, Ulm, Germany; LBI-ACR VIEnna u. ACR-ITR VIEnna, Oncol. KFJ, Vienna, Austria; Klin der Stadt, Ludwigshafen, Germany; Univ Hosp, Innsbruck, Austria; Univ Hosp, Heidelberg, Germany; Klin rechts der Isar der TU Muenchen, Munich, Germany; Martin-Luther-University Hosp, Halle, Germany; Merck KGaA, Darmstadt, Germany; Univ Hosp, Mainz, Germany
| | - E. Woell
- Univ Hosp, Ulm, Germany; LBI-ACR VIEnna u. ACR-ITR VIEnna, Oncol. KFJ, Vienna, Austria; Klin der Stadt, Ludwigshafen, Germany; Univ Hosp, Innsbruck, Austria; Univ Hosp, Heidelberg, Germany; Klin rechts der Isar der TU Muenchen, Munich, Germany; Martin-Luther-University Hosp, Halle, Germany; Merck KGaA, Darmstadt, Germany; Univ Hosp, Mainz, Germany
| | - T. Herrmann
- Univ Hosp, Ulm, Germany; LBI-ACR VIEnna u. ACR-ITR VIEnna, Oncol. KFJ, Vienna, Austria; Klin der Stadt, Ludwigshafen, Germany; Univ Hosp, Innsbruck, Austria; Univ Hosp, Heidelberg, Germany; Klin rechts der Isar der TU Muenchen, Munich, Germany; Martin-Luther-University Hosp, Halle, Germany; Merck KGaA, Darmstadt, Germany; Univ Hosp, Mainz, Germany
| | - F. Lordick
- Univ Hosp, Ulm, Germany; LBI-ACR VIEnna u. ACR-ITR VIEnna, Oncol. KFJ, Vienna, Austria; Klin der Stadt, Ludwigshafen, Germany; Univ Hosp, Innsbruck, Austria; Univ Hosp, Heidelberg, Germany; Klin rechts der Isar der TU Muenchen, Munich, Germany; Martin-Luther-University Hosp, Halle, Germany; Merck KGaA, Darmstadt, Germany; Univ Hosp, Mainz, Germany
| | - D. Arnold
- Univ Hosp, Ulm, Germany; LBI-ACR VIEnna u. ACR-ITR VIEnna, Oncol. KFJ, Vienna, Austria; Klin der Stadt, Ludwigshafen, Germany; Univ Hosp, Innsbruck, Austria; Univ Hosp, Heidelberg, Germany; Klin rechts der Isar der TU Muenchen, Munich, Germany; Martin-Luther-University Hosp, Halle, Germany; Merck KGaA, Darmstadt, Germany; Univ Hosp, Mainz, Germany
| | - K. Olchowka
- Univ Hosp, Ulm, Germany; LBI-ACR VIEnna u. ACR-ITR VIEnna, Oncol. KFJ, Vienna, Austria; Klin der Stadt, Ludwigshafen, Germany; Univ Hosp, Innsbruck, Austria; Univ Hosp, Heidelberg, Germany; Klin rechts der Isar der TU Muenchen, Munich, Germany; Martin-Luther-University Hosp, Halle, Germany; Merck KGaA, Darmstadt, Germany; Univ Hosp, Mainz, Germany
| | - T. Hoehler
- Univ Hosp, Ulm, Germany; LBI-ACR VIEnna u. ACR-ITR VIEnna, Oncol. KFJ, Vienna, Austria; Klin der Stadt, Ludwigshafen, Germany; Univ Hosp, Innsbruck, Austria; Univ Hosp, Heidelberg, Germany; Klin rechts der Isar der TU Muenchen, Munich, Germany; Martin-Luther-University Hosp, Halle, Germany; Merck KGaA, Darmstadt, Germany; Univ Hosp, Mainz, Germany
| | - H. J. Schmoll
- Univ Hosp, Ulm, Germany; LBI-ACR VIEnna u. ACR-ITR VIEnna, Oncol. KFJ, Vienna, Austria; Klin der Stadt, Ludwigshafen, Germany; Univ Hosp, Innsbruck, Austria; Univ Hosp, Heidelberg, Germany; Klin rechts der Isar der TU Muenchen, Munich, Germany; Martin-Luther-University Hosp, Halle, Germany; Merck KGaA, Darmstadt, Germany; Univ Hosp, Mainz, Germany
| |
Collapse
|
23
|
Hoffmann JC, Zeitz M, Bischoff SC, Brambs HJ, Bruch HP, Buhr HJ, Dignass A, Fischer I, Fleig W, Fölsch UR, Herrlinger K, Höhne W, Jantschek G, Kaltz B, Keller KM, Knebel U, Kroesen AJ, Kruis W, Matthes H, Moser G, Mundt S, Pox C, Reinshagen M, Reissmann A, Riemann J, Rogler G, Schmiegel W, Schölmerich J, Schreiber S, Schwandner O, Selbmann HK, Stange EF, Utzig M, Wittekind C. [Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German society of Digestive and Metabolic Diseases and the competence network on inflammatory bowel disease]. Z Gastroenterol 2004; 42:979-83. [PMID: 15455267 DOI: 10.1055/s-2004-813510] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
- J C Hoffmann
- Medizinische Klinik I mit Schwerpunkt Gastroenterologie/Infektiologie/Rheumatologie, Charité, Universitätsmedizin Berlin.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Weser S, Riemann J, Seifart KH, Meissner W. Assembly and isolation of intermediate steps of transcription complexes formed on the human 5S rRNA gene. Nucleic Acids Res 2003; 31:2408-16. [PMID: 12711686 PMCID: PMC154231 DOI: 10.1093/nar/gkg345] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
By employing purified transcription factors and RNA polymerase III (pol III), we generated active pol III transcription complexes on the human 5S rRNA gene. These large complexes were separated by size exclusion chromatography from non- incorporated proteins. In addition, we succeeded in isolating specific intermediate stages of complex formation. Such isolated partial complexes require complementation with the missing activities for full transcription activity. One central finding is that a 5S DNA-TFIIIA-TFIIIC2-TFIIIBbeta complex could be isolated which had been assembled in the absence of the general pol III transcription factor IIIC1. Thus TFIIIC1 is not an assembly factor for other transcription factors. Although pol III has the potential to bind unspecifically to DNA, such polymerase molecules cannot be rendered initiation competent by direct recruitment to a 5S DNA-TFIIIA-TFIIIC2- TFIIIBbeta complex, but this process strictly requires additional TFIIIC1 activity. This clearly demonstrates that in contrast to yeast cells, hTFIIIB(beta), although required, does not suffice for the functional recruitment of polymerase III. These data document that TFIIIC1 is the second transcription factor required for the recruitment of pol III in mammalian cells.
Collapse
Affiliation(s)
- Stephan Weser
- Institut für Molekularbiologie und Tumorforschung, Philipps Universität Marburg, Lahnstrasse 3, D-35037 Marburg, Germany
| | | | | | | |
Collapse
|
25
|
Eickhoff A, Reinacher-Schick A, Schmiegel W, Riemann J. Kolorektalkarzinom. Dtsch Med Wochenschr 2002. [DOI: 10.1055/s-2002-22086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
26
|
Jakobs R, Riemann J. Gallensteine - Der konkrete Fall. Dtsch Med Wochenschr 2001. [DOI: 10.1055/s-2001-16306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
27
|
Schilling D, Jakobs R, Peitz U, Sulliga M, Stolte M, Riemann J, Labenz J. Diagnostic accuracy of (13)C-urea breath test in the diagnosis of Helicobacter pylori infection in patients with partial gastric resection due to peptic ulcer disease: a prospective multicenter study. Digestion 2001; 63:8-13. [PMID: 11173894 DOI: 10.1159/000051866] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
AIMS We investigated the diagnostic properties of the (13)C-urea breath test ((13)C-UBT) prospectively. These are well validated in nonresected patients before and after treatment of Helicobacter pylori infection but not in patients with partial gastric resection due to peptic ulcer disease. METHODS Hospitalized patients with previous gastric resection and indications for upper gastrointestinal endoscopy were recruited for the study. Biopsy specimens were obtained from the fundus mucosa and the gastric remnant adjacent to the gastroenteric anastomosis for histological examination and rapid urease test (HUT test). Histological slides were evaluated after hematoxylin and eosin and Warthin-Starry dye staining. 200 ml orange juice was given orally after two baseline breath samples had been taken, and 30 min after ingestion of 75 mg (13)C urea two more breath samples were obtained and analyzed by ratio mass spectrometry. The Warthin-Starry dye-stained sample was taken as reference. RESULTS 68 patients (47 male, 21 female, mean age 62 years; 52 Billroth II resection, 17 Billroth I resection) were included in the study. The overall prevalence of histologically proven H. pylori infection was 36.7%. The sensitivity of the (13)C-UBT was 52%, the specificity 93%. The positive predictive value was 81.25%, the negative predictive value 76.9% and the accuracy was 77.9%. The sensitivity of the HUT test reached 60%, and the specificity 97%. CONCLUSION The diagnostic accuracy of (13)C-UBT compared with the Warthin-Starry dye staining is low. The breath test, performed in the above-described manner, cannot be recommended as a noninvasive diagnostic tool for diagnosis of H. pylori infection in patients after partial gastrectomy as a result of peptic ulcer disease.
Collapse
Affiliation(s)
- D Schilling
- Medical Department C (Gastroenterology and Hepatology), Klinikum Ludwigshafen, Academic Hospital, Johannes Gutenberg University, Bremserstrasse 79, D-67063 Ludwigshafen/Rhine, Germany.
| | | | | | | | | | | | | |
Collapse
|
28
|
Stange EF, Riemann J, von Herbay A, Lochs H, Fleig WE, Schölmerich J, Kruis W, Porschen R, Bruch HP, Zeitz M, Schreiber S, Moser G, Matthes H, Selbmann HK, Goebell H, Caspary WF. [Diagnosis and therapy of ulcerative colitis--results of an evidence-based consensus conference of the German Society of Digestive and Metabolic Diseases]. Z Gastroenterol 2001; 39:19-20. [PMID: 11215358 DOI: 10.1055/s-2001-10692] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Affiliation(s)
- E F Stange
- Abteilung Innere Medizin 1 Robert-Bosch-Krankenhaus Auerbachstrasse 110 70376 Stuttgart.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Riemann J. [Eradication euphoria is passé. Does H. pylori protect against reflux? Interview by Dr. Brigitte Moreano]. MMW Fortschr Med 2000; 142:8. [PMID: 11050882] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
|
30
|
Fleig WE, Laudage G, Sommer H, Wellmann W, Stange EF, Riemann J. Prospective, randomized, double-blind comparison of benzalazine and sulfasalazine in the treatment of active ulcerative colitis. Digestion 1988; 40:173-80. [PMID: 2906888 DOI: 10.1159/000199652] [Citation(s) in RCA: 26] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Benzalazine (salicylazobenzoic acid, SAB), a 5-azo derivative of 5-aminosalicylic acid, has been designed as a new therapeutic agent for the treatment of inflammatory bowel disease which might lack the frequent side effects caused by the sulfapyridine moiety of the sulfasalazine molecule (SASP). Here, we report on a prospective, randomized, double-blind comparison of SAB and SASP in patients with an acute relapse of ulcerative colitis. 43 patients with an acute relapse of ulcerative colitis proven by the pertinent endoscopic-macroscopic and histologic criteria were randomized to receive a 6-week course of either 1 g SASP (n = 21) or the equivalent dose of 0.72 g SAB (n = 22) three times a day. Both groups were comparable with respect to demographic data, previous duration and extension of the disease as well as clinical, endoscopic and histologic severity of the relapse. 1 patient on SASP had to be removed from the study due to side effects, while 3 patients on SAB were removed due to rapid worsening of the disease requiring either surgery (1 patient with toxic megacolon) or additional steroid treatment (2 patients). 2 SAB patients were lost to follow-up after substantial improvement had been observed within the first 3 weeks of treatment. In the remaining patients (20 SASP, 17 SAB), stool frequency, stool consistency and macroscopic appearance as well as histology of the diseased mucosa were improved within 6 weeks, with no significant difference between the two groups with respect to any of the parameters recorded. Side effects were recorded in 5 patients on SASP (3 with nausea, 1 with pruritus and 1 with a generalized exanthema) and in 3 patients on SAB (all nausea and vomiting; difference not statistically significant). We conclude that SAB and SASP in equivalent doses are of similar efficacy in the treatment of active ulcerative colitis.
Collapse
Affiliation(s)
- W E Fleig
- Medizinische Universitätskliniken Ulm, BRD
| | | | | | | | | | | |
Collapse
|
31
|
Miklautz H, Riemann J, Vidic HJ. The Molecular Weight Distribution of Heparin Determined with a HPLC-LALLS Coupling Technique. ACTA ACUST UNITED AC 1986. [DOI: 10.1080/01483918608074136] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
32
|
Düring A, Rödl W, Koch B, Riemann J. [Diagnosis of choledochal cysts. The methodological value of imaging procedures]. ROFO-FORTSCHR RONTG 1985; 142:380-5. [PMID: 2986212 DOI: 10.1055/s-2008-1052671] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
For 10 cases in which we detected cysts in the choledochus ourselves comparing traditional radiological methods (infusion-cholegram, ERC, scintigraphy, barium meal examination, angiography) with recent imaging procedures (ultrasound, CT, NMR) the following sequence of procedures proved to be favorable: Screening methods are ultrasound and infusion-cholegram. CT and NMR furnish good presentations of the intra- and extrahepatic dilatations of the bile duct. ERC still represents the best methods for demonstration of an extrahepatic cyst of the choledochus. Hepato-biliary functional scintigraphy is performed as a supplement. Barium meal examination and coeliacography furnish a small diagnostic contribution only.
Collapse
|
33
|
Doldi K, Manger B, Koch B, Riemann J, Hermanek P, Kalden JR. Spontaneous suppressor cell activity in the peripheral blood of patients with malignant and chronic inflammatory bowel diseases. Clin Exp Immunol 1984; 55:655-63. [PMID: 6231146 PMCID: PMC1535940] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
Abstract
Fifteen patients with colorectal tumours, 15 patients with Crohn's disease (CD) and two groups of normal controls were investigated for the presence of spontaneous suppressor cell activity (SSCA) in peripheral blood mononuclear cells (PBMC). In comparison to the age and sex matched controls patients with colorectal carcinoma exhibited a significant increase in SSCA (P less than 0.01). No evidence could be obtained that the suppressive effect was due to a soluble factor such as prostaglandins. In contrast, patients suffering from CD presented a decreased SSCA. No correlation was obtained between the enhanced SSCA in tumour patients and the clinical stage of the disease, levels of oncofetal antigens or serum immune complexes. Likewise in patients with CD no correlation was found between decreased SSCA and CD index or different serum parameters. When PBMC of the different test groups were incubated with histamine or cimetidine before they were added to the indicator system the suppressive activity remained unchanged. Also pre-incubation of normal PBMC with alpha-fetoprotein or carcinoembryonic antigen did not change the spontaneous suppressor cell activity. Whether the significantly enhanced in vivo activity of spontaneous suppressor cells in patients with colorectal carcinoma is one of the multifactorial mechanisms leading to the establishment of cancer or whether it rather represents a reflection of the immune system on colorectal tumour antigens remains unsolved.
Collapse
|
34
|
Gebhardt C, Gall FP, Lux G, Riemann J, Link W. [Retrograde pancreatic duct imaging and surgical tactics in hemorrhagic necrotizing pancreatitis. Preliminary report]. Chirurg 1983; 54:801-4. [PMID: 6661966] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
In patients with haemorrhagic necrotizing pancreatitis who are scheduled for surgery we have been carrying out a preoperative retrograde investigation of the pancreatic duct system for the past months. The results in, to date, ten patients revealed four different morphological findings of importance for the surgical tactic: 1. A normal pancreatic duct system with no signs of fistulae: only peripancreatic necrosectomy is required. - 2. Contrast medium leaks via a ductal fistula: left resection including the removal of the fistulous area must be done. - 3. Normal duct system with complete segmental parenchymal staining, representing total necrosis in this region: left resection of the pancreas. - 4. Duodenoscopically demonstrable perforation into the duodenum of a necrotic cavity in the head of the pancreas: conservative management only, no surgery, since this lesion resulting in drainage of the necrotic cavity into the bowel permits self-healing, while the site of the perforation within the necrotic wall cannot be dealt with by surgery. - The experience gained so far indicates that the surgical tactic can be determined with greater selectivity by the use of ERP.
Collapse
|
35
|
Szöllösi A, Riemann J, Marcaillou C. Localization of the blood-testis barrier in the testis of the moth, Anagasta küehniella. J Ultrastruct Res 1980; 72:189-99. [PMID: 7420533 DOI: 10.1016/s0022-5320(80)90056-8] [Citation(s) in RCA: 30] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
|
36
|
Schmack B, Schenk J, Riemann J, Koch H, Rösch W. Dissolution of biliary-duct stones with mono-octanoin. Lancet 1979; 2:423-4. [PMID: 89485 DOI: 10.1016/s0140-6736(79)90441-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
37
|
Hartwich G, Riemann J, Krönert E. [Congenital dyserythropoietic anemia type II. Another case report]. Med Klin 1976; 71:2117-22. [PMID: 1004360] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Hematologic evaluation of a 29-year old man with jaundice since childhood demonstrated the characteristic findings of congenital dyserythropoietic anemia (CDA) type II. This type is characterized by ineffective erythropoiesis, multinuclearity of erythroblasts, electron-microscopic abnormalities of the red cell membrane, and abnormal serological reactions. Because of severe anemia repeated transfusions were necessary. After splenectomy thrombosis of the portal vein occurred. The patient died from hemorrhage due to ruptured esophageal varices.
Collapse
|
38
|
Mörl M, Fuchs H, Riemann J. [Rare fistulation in enterocolitis regionalis (Crohn's disease) (author's transl)]. Med Klin 1976; 71:814-9. [PMID: 1272174] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
The transmural inflammation in Crohn's disease, the variable localization of the disease and the tendency to a descending spread, all lead to a multitude of possible fistulae, the presence of which is often difficult to demonstrate. This is a report on 5 unusual fistula systems: in 2 cases entero-enteral (one of which with hydronephrosis), 1 case of rectovaginal fistula, 1 case of a branched fistula system in the right buttock, 1 case of fistulae between an abscess system in the spleen "bed" and the greater curvature of the stomach. A radiological and endoscopic diagnosis is important since surgically opened fistula systems heal only with great difficulty or not at all.
Collapse
|
39
|
Miklautz H, Riemann J. [The associative behaviour of methylglucamine salts of the dicarboxylic acid dianilides of 3-carboxy-2,4,6-triiodoaniline in aqueous solutions (author's transl)]. Arch Pharm (Weinheim) 1975; 308:760-8. [PMID: 1200792 DOI: 10.1002/ardp.19753081008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
40
|
Gerhards E, Gutsche H, Riemann J. [Biodynamics of 1,2 alpha-methyl-6-chloro-pregna-4,6-diene-17 alpha-acetoxy-3,20-dione (cyproterone acetate) after oral administration in man. On alkyl-substituted steroids. IX]. Arzneimittelforschung 1973; 23:1550-5. [PMID: 4361164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
41
|
Riemann J, Röpke H, Holzmann K. [Simulation of the metabolism kinetics of progesteron-4-14C in organ-cultures of fetal testis and fetal adrenal glands using an analog computer]. Int Z Klin Pharmakol Ther Toxikol 1971; 4:281-8. [PMID: 5579250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
42
|
Riemann J, Röpke H, Gerhards E, Kolb KH, Gibian H. [Simulation of the biodynamics of glycodiazine with the analog computer]. Arzneimittelforschung 1968; 18:1443-5. [PMID: 5756066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
43
|
|
44
|
Missmahl HP, Riemann J. [Simple determination of microangiopathy of the capillaries of the rectal mucosa in diabetics]. Klin Wochenschr 1968; 46:374-6. [PMID: 5686106 DOI: 10.1007/bf01734129] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
45
|
Bohlmann F, Riemann J. Über den Mechanismus der Jacobsen-Reaktion. Angew Chem Int Ed Engl 1963. [DOI: 10.1002/ange.19630751415] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|